Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Infection01:20

Infection

11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

524
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

676
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
676
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection01:26

Stages of Infection

64.7K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

DNA damage-associated vesicle production in <i>Stenotrophomonas maltophilia</i> is mediated by the maltocin endolysin.

Journal of bacteriology·2026
Same author

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same author

Small intestinal organoids as a model to study interactions of <i>C. suis</i> with its porcine host.

Frontiers in microbiology·2026
Same author

Predicting Agitation Stability of Monoclonal Antibodies during Developability Assessment.

Molecular pharmaceutics·2026
Same author

Cationic mRNA Lipid Nanoparticles for Ex Vivo NanoCAR-T Cell Engineering.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

A Nanobody-Based Toolbox to Probe ApoE4 in the Secretory Pathway and Cytosol.

Cells·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K

Ciencia básica y patogénesis

Laure Vandevelde1, Olivier Zwaenepoel1, Kevin Braeckmans1

  • 1Ghent University, Ghent, Oost-Vlaanderen, Belgium.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Los investigadores desarrollaron nanobodies anti-apoE4 para estudiar el riesgo de la enfermedad de Alzheimer (EA). Estos nanobodies se dirigen a la apolipoproteína E4 (apoE4) en neuronas humanas, ofreciendo una nueva herramienta para comprender la patogénesis de la EA.

Palabras clave:
nanobodiesapolipoproteína E4enfermedad de AlzheimerneuronasiPSC

Más Videos Relacionados

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

11.5K
A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

6.0K
Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
08:38

Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses

Published on: February 22, 2019

6.3K

Área de la Ciencia:

  • Neurociencia
  • Genética
  • Biotecnología

Sus antecedentes:

  • El alelo APOE-ε4 es el principal factor de riesgo genético para la enfermedad de Alzheimer (EA), pero su papel preciso en la patogénesis de la EA sigue sin estar claro.
  • La apolipoproteína E4 (apoE4), codificada por APOE-ε4, está implicada en la EA, lo que requiere herramientas para estudiar sus funciones celulares.
  • Los nanobodies presentan un enfoque novedoso para la focalización intracelular y el estudio de los efectos patológicos de apoE4 en modelos de EA.

Objetivo del estudio:

  • Desarrollar y caracterizar nuevos nanobodies que se dirijan específicamente a la isoforma apoE4 de la apolipoproteína E.
  • Utilizar estos nanobodies anti-apoE4 como intrabodies dentro de neuronas derivadas de iPSC para modelar la patogénesis de la EA.
  • Investigar el impacto de apoE4 en los niveles de beta amiloide 1-42 y fosfo-tau en neuronas humanas y evaluar el potencial terapéutico de la degradación de apoE4 mediada por nanobodies.

Principales métodos:

  • Inmunización de una llama con apoE4 para generar un repertorio de nanobodies.
  • Caracterización de nanobodies mediante ensayos de inmunoprecipitación para determinar la especificidad contra apoE4, apoE3 y sus extremos.
  • Cotransfección de nanobodies y apoE4 en células HEK293T para evaluar la funcionalidad intracelular y la colocalización.
  • Diferenciación de líneas de iPSC homocigotas para apoE4 y apoE3 en neuronas para el análisis comparativo de biomarcadores de EA.
  • Administración de nanobodies diseñados con etiquetas de degradación en neuronas a través de fotoporación inducida por láser para inducir la degradación de apoE4.

Principales resultados:

  • Se generó y caracterizó con éxito un panel de nanobodies específicos anti-apoE4.
  • Se identificaron intrabodies funcionales capaces de dirigirse a la apoE4 intracelular.
  • Se estableció un modelo de célula humana in vitro utilizando neuronas derivadas de iPSC de portadores de apoE4 para estudios de EA.
  • Se anticipan niveles elevados de beta amiloide 1-42 y fosfo-tau en neuronas apoE4 en comparación con neuronas apoE3.
  • Se espera que la degradación de apoE4 utilizando nanobodies dirigidos module los niveles de proteínas relacionados con la EA.

Conclusiones:

  • Los nanobodies son herramientas eficaces para la focalización y manipulación intracelular de apoE4.
  • Este enfoque proporciona una plataforma poderosa para investigar el papel de apoE4 en la patogénesis de la enfermedad de Alzheimer.
  • Estudios adicionales pueden explorar las implicaciones terapéuticas de la reducción de apoE4 mediada por nanobodies en la EA.